• Home
  • NEW DAY MEDICINE
  • 6 (80) 2025
  • 156 -6 (80) 2025 - Keldiyorova Z.D., Gaffarova F.Kh. - COMPARATIVE CHARACTERISTICS OF LABORATORY PARAMETERS OF INFLAMMATORY DISEASES OF THE UPPER RESPIRATORY TRACT IN PREGNANT WOMEN WITH CONFIRMED COVID-19

156 -6 (80) 2025 - Keldiyorova Z.D., Gaffarova F.Kh. - COMPARATIVE CHARACTERISTICS OF LABORATORY PARAMETERS OF INFLAMMATORY DISEASES OF THE UPPER RESPIRATORY TRACT IN PREGNANT WOMEN WITH CONFIRMED COVID-19

COMPARATIVE CHARACTERISTICS OF LABORATORY PARAMETERS OF INFLAMMATORY DISEASES OF THE UPPER RESPIRATORY TRACT IN PREGNANT WOMEN WITH CONFIRMED COVID-19

Keldiyorova Z.D. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Gaffarova F.Kh. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Mirzoeva M.R. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Thus, clinical indicators of inflammatory diseases of the upper respiratory tract in patients with coronavirus infection are the basis for carrying out therapeutic measures to prevent the occurrence of severe complications associated with COVID-19.

Keywords: COVID-19, pregnant women, clinical picture.

First page

802

Last page

807

For citation:Keldiyorova Z.D., Gaffarova F.Kh., Mirzoeva M.R. - COMPARATIVE CHARACTERISTICS OF LABORATORY PARAMETERS OF INFLAMMATORY DISEASES OF THE UPPER RESPIRATORY TRACT IN PREGNANT WOMEN WITH CONFIRMED COVID-19//New Day in Medicine 6(80)2025 802-807 https://newdayworldmedicine.com/en/new_day_medicine/6-80-2025

List of References

  1. Байжданов А.К., Хикматуллаева А.С., Ибадуллаева Н.С. и др. Нарушение системы свертывания крови при COVID-19. // Инфекция, иммунитет и фармакология. №1 2021 с.7-12.
  2. Cao Y., Liu X., Xiong L. et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS CoV 2: a systematic review and meta analysis. // J. Med. Virol., 2020; doi: 10.1002/jmv.25 822.
  3. Wang D, Hu B, Hu C et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020.
  4. Chen N, Zhou M, Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet.2020;395:507-513.,
  5. World Health Organization. Novel Coronavirus (2019-nCoV) situation reports. https://www.worldometers.info/coronavirus/ Accessed: 05 July. 2022.
  6. Иноятов А.Ш. и др. Оценка состояния беременных женщин с диабетом, при заражении COVID-19 //Новый день в медицине. – 2020. – №. 2.С. 101-103.
  7. Cao Y., Liu X., Xiong L. et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS CoV 2: a systematic review and meta analysis. J. Med. Virol., 2020.
  8. Najim M, Rahhal A, Khir F, et al. Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: A prospective observational study. Rheumatol Int 2021;41:1243–1252;
  9. Wang L, He WB, Yu XM. et al. Prolonged prothrombin time at admission predicts poor clinical outcome in COVID-19 patients. World J Clin Cases 2020; 8(19): 4370-4379.
  10. Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844–847.
  11. Huan H., Lan Y., Liu R., et al. Prominent changes in blood coagulation of patients with SARS-Cov2 infection. Clin Chem Lab Med. 2020; 58(7): 1116–1120. DOI: 10/1515/cclm-2020-0188.
  12. Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497–506. DOI: 10.1016/S0140-6736(20)30183-5.
  13. Guan W.J., Ni Z.Y., Hu Y. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020; 382 (18): 1708–1720. DOI: 10.1056/NEJMoa2002032.
  14. Yin S., Huang M., Li D., Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J. Thromb. Thrombolysis. [Preprint. Posted: 2020, Apr. 3.
  15. Zhang Y., Xiao M., Zhang S., et al. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N. Engl. J. Med., 2020, Vol. 382, no. 17, e38
  16. Harzallah I., Debliquis A., Drénou B. Lupus anticoagulant is frequent in patients with COVID-19. J. Thromb. Haemost., 2020, Vol. 18, no. 8, pp. 2064-2065.
  17. Borghi M.O., Beltagy A., Garrafa E., et al. Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome. Front. Immunol., 2020, Vol. 11, 584241.

    file

    download